Description
Doxazosin is a quinazoline α1-adrenergic receptor inhibitor that exhibits antihypertensive and vasodilatory activities. Doxazosin is clinically used to treat hypertension and benign prostatic hyperplasia. Doxazosin induces Fas-mediated apoptosis in benign and malignant prostate cells.
References
Shannon R, Chaudhry M. Effect of alpha1-adrenergic receptors in cardiac pathophysiology. Am Heart J. 2006 Nov;152(5):842-50. PMID: 17070143.
Garrison JB, Kyprianou N. Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res. 2006 Jan 1;66(1):464-72. PMID: 16397262.
Kyprianou N. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance. J Urol. 2003 Apr;169(4):1520-5. PMID: 12629407.